Therapies
Friday, February 22nd, 2013
Neurology: February 13, 2013 Objectives: Data on long-term outcome after IV thrombolysis (IVT) are sparse. Our goals were to 1) estimate annual survival, and 2) evaluate determinants for an unfavorable long-term outcome after IVT for stroke. Methods: This observational study is based on the IVT registry of the University Hospital Basel. A structured telephone interview was used to […]
Therapies
Friday, February 22nd, 2013
STROKEAHA: February 12, 2013 Background and Purpose—Despite the findings that motor imagery and execution are supposed to share common neural networks, previous studies using imagery-based rehabilitation have revealed inconsistent results. In the present study, we investigated whether feedback of cortical activities (neurofeedback) using near-infrared spectroscopy could enhance the efficacy of imagery-based rehabilitation in stroke patients. Read […]
Therapies
Friday, February 22nd, 2013
American Heart Association: February 08, 2013 American Stroke Association Late-Breaking Science Report Report: Abstract LB 10 Embargoed until 7 a.m. HT/noon ET on Friday, Feb. 8, 2013 Study Highlights: Surgery to improve blood flow to the brain does not reverse cognitive problems associated with low blood flow in patients who have experienced a stroke or mini-stroke. […]
Therapies
Friday, February 22nd, 2013
CIRCULATIONAHA: February 7, 2013 Background—Comprehensive stroke centers allow for regionalization of subspecialty stroke care. Efficacy of endovascular treatments, however, may be limited by delays in patient transfer. Our goal was to identify where these delays occurred and to assess the impact of such delays on patient outcome. Read more
Therapies
Friday, February 22nd, 2013
STROKEAHA: February 6, 2013, Background and Purpose—Intravenous thrombolysis with alteplase is approved for acute ischemic stroke, but its use is limited by numerous contraindications and warnings arising from trial selection criteria or expert opinions. We examined outcomes from alteplase-treated versus untreated patients, registered in a trials archive, according to presence or absence of specified contraindications and […]
News
Friday, February 22nd, 2013
Neurology: February 13, 2013 Objective: CHADS2 and CHA2DS2-VASc scores are used to assess stroke risk in patients with atrial fibrillation (AF). We investigated whether these scores are associated with stroke outcome in non-AF stroke patients. Methods: Consecutive patients with acute first-ever ischemic stroke but without AF were classified into subgroups according to prestroke CHADS2 and CHA2DS2-VASc scores and followed up […]
News
Friday, February 22nd, 2013
Health Day News: February 7, 2013 THURSDAY, Feb. 7 (HealthDay News) — Doctors may sometimes be too pessimistic about a patient’s potential for recovery after a major bleeding incident occurs in the brain, a new study suggests. As a result, some families could be deciding to stop their loved one’s life support too soon, pre-empting […]
News
Friday, February 22nd, 2013
STROKEAHA: February 7, 2013 Background and Purpose—There have been no multicity studies on the acute effects of air pollution on stroke mortality in China. This study was undertaken to examine the associations between daily stroke mortality and outdoor air pollution (particulate matter <10 μm in aerodynamic diameter, sulfur dioxide, and nitrogen dioxide) in 8 Chinese cities. […]
News
Friday, February 22nd, 2013
Plos One: February 4, 2013 Background Little is known about the incidence and risk of seizures after stroke in young adults. Especially in the young seizures might dramatically influence prognosis and quality of life. We therefore investigated the long-term incidence and risk of post-stroke epilepsy in young adults with a transient ischemic attack (TIA), ischemic […]
News
Friday, February 22nd, 2013
J NeuroIntervent Surgery: January 19, 2013 Background Despite increased recanalization rates in the treatment of acute ischemic stroke, the percentage of patients with a good clinical outcome of all those treated has not risen above 50%. This 50% barrier may be broken by improving the criteria for treatment selection. This study investigated the addition of the […]